764 related articles for article (PubMed ID: 18242515)
1. Significance of CD90+ cancer stem cells in human liver cancer.
Yang ZF; Ho DW; Ng MN; Lau CK; Yu WC; Ngai P; Chu PW; Lam CT; Poon RT; Fan ST
Cancer Cell; 2008 Feb; 13(2):153-66. PubMed ID: 18242515
[TBL] [Abstract][Full Text] [Related]
2. Identification of local and circulating cancer stem cells in human liver cancer.
Yang ZF; Ngai P; Ho DW; Yu WC; Ng MN; Lau CK; Li ML; Tam KH; Lam CT; Poon RT; Fan ST
Hepatology; 2008 Mar; 47(3):919-28. PubMed ID: 18275073
[TBL] [Abstract][Full Text] [Related]
3. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties.
Chiba T; Kita K; Zheng YW; Yokosuka O; Saisho H; Iwama A; Nakauchi H; Taniguchi H
Hepatology; 2006 Jul; 44(1):240-51. PubMed ID: 16799977
[TBL] [Abstract][Full Text] [Related]
4. CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells.
Yamazaki H; Nishida H; Iwata S; Dang NH; Morimoto C
Biochem Biophys Res Commun; 2009 May; 383(2):172-7. PubMed ID: 19341705
[TBL] [Abstract][Full Text] [Related]
5. A CD90(+) tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer.
Tang KH; Dai YD; Tong M; Chan YP; Kwan PS; Fu L; Qin YR; Tsao SW; Lung HL; Lung ML; Tong DK; Law S; Chan KW; Ma S; Guan XY
Cancer Res; 2013 Apr; 73(7):2322-32. PubMed ID: 23382045
[TBL] [Abstract][Full Text] [Related]
6. Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells.
Liu S; Li N; Yu X; Xiao X; Cheng K; Hu J; Wang J; Zhang D; Cheng S; Liu S
Gastroenterology; 2013 May; 144(5):1031-1041.e10. PubMed ID: 23376424
[TBL] [Abstract][Full Text] [Related]
7. Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.
Jiang J; Zhang Y; Chuai S; Wang Z; Zheng D; Xu F; Zhang Y; Li C; Liang Y; Chen Z
Oncogene; 2012 Feb; 31(6):671-82. PubMed ID: 21743497
[TBL] [Abstract][Full Text] [Related]
8. The Notch pathway promotes the cancer stem cell characteristics of CD90+ cells in hepatocellular carcinoma.
Luo J; Wang P; Wang R; Wang J; Liu M; Xiong S; Li Y; Cheng B
Oncotarget; 2016 Feb; 7(8):9525-37. PubMed ID: 26848615
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic potential of CD44+ CD90+ multipotent CNS stem cells in vitro.
Oishi K; Ito-Dufros Y
Biochem Biophys Res Commun; 2006 Oct; 349(3):1065-72. PubMed ID: 16962069
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.
Tomuleasa C; Soritau O; Rus-Ciuca D; Pop T; Todea D; Mosteanu O; Pintea B; Foris V; Susman S; Kacsó G; Irimie A
J Gastrointestin Liver Dis; 2010 Mar; 19(1):61-7. PubMed ID: 20361077
[TBL] [Abstract][Full Text] [Related]
11. Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines.
Yan X; Luo H; Zhou X; Zhu B; Wang Y; Bian X
Oncol Rep; 2013 Dec; 30(6):2733-40. PubMed ID: 24101104
[TBL] [Abstract][Full Text] [Related]
12. Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma--human and cell culture study.
Fujii T; Zen Y; Harada K; Niwa H; Masuda S; Kaizaki Y; Watanabe K; Kawashima A; Nakanuma Y
Hum Pathol; 2008 Aug; 39(8):1185-96. PubMed ID: 18547618
[TBL] [Abstract][Full Text] [Related]
13. Evidence of CD90+CXCR4+ cells as circulating tumor stem cells in hepatocellular carcinoma.
Zhu L; Zhang W; Wang J; Liu R
Tumour Biol; 2015 Jul; 36(7):5353-60. PubMed ID: 25672610
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of liver cancer stem cells by RNA-sequencing.
Ho DW; Yang ZF; Yi K; Lam CT; Ng MN; Yu WC; Lau J; Wan T; Wang X; Yan Z; Liu H; Zhang Y; Fan ST
PLoS One; 2012; 7(5):e37159. PubMed ID: 22606345
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a stem-like population in hepatocellular carcinoma MHCC97 cells.
Zhang N; Li R; Tao KS; Cao DY; Ti ZY; Ding R; Cai L; Zhang FQ; Dou KF
Oncol Rep; 2010 Mar; 23(3):827-31. PubMed ID: 20127026
[TBL] [Abstract][Full Text] [Related]
16. Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells.
Park JR; Kim RJ; Lee YK; Kim SR; Roh KJ; Oh SH; Kong G; Kang KS; Nam JS
J Hepatol; 2011 Jan; 54(1):122-31. PubMed ID: 20952084
[TBL] [Abstract][Full Text] [Related]
17. Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.
Palapattu GS; Wu C; Silvers CR; Martin HB; Williams K; Salamone L; Bushnell T; Huang LS; Yang Q; Huang J
Prostate; 2009 May; 69(7):787-98. PubMed ID: 19189306
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem cells in head and neck squamous cell carcinoma.
Ailles L; Prince M
Methods Mol Biol; 2009; 568():175-93. PubMed ID: 19582427
[TBL] [Abstract][Full Text] [Related]
19. Distinct biological characterization of the CD44 and CD90 phenotypes of cancer stem cells in gastric cancer cell lines.
Shu X; Liu H; Pan Y; Sun L; Yu L; Sun L; Yang Z; Ran Y
Mol Cell Biochem; 2019 Sep; 459(1-2):35-47. PubMed ID: 31073886
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma model cell lines with two distinct migration modes.
Lee IJ; Li ZS; Lee YN; Jin XJ; Lee JH; Kim SY; Kim NS; Lee DC; Lee HS; Yang SJ; Kim SJ; Yeom YI
Biochem Biophys Res Commun; 2006 Aug; 346(4):1217-27. PubMed ID: 16793003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
